NYSE·Healthcare·USD
Henter pris…
Værdiansættelse (TTM)
P/E
0,6
1st %ile · 158pEV/EBITDA
4,7
26th %ile · 83pP/B
—
P/S
0,0
0th %ile · 356pEV/Sales
0,5
11th %ile · 356pDiv yield
9,2 %
94th %ile · 60pRegnskabsdata (SEC EDGAR)
Årsregnskab (senest 5 år)
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | |
|---|---|---|---|---|---|
| Omsætning | 12.485,0 mio. | 12.634,0 mio. | 12.490,0 mio. | 12.211,0 mio. | 12.368,0 mio. |
| Bruttoresultat | — | — | — | — | — |
| Nettoresultat | 509,0 mio. | -516,0 mio. | -133,0 mio. | 46,0 mio. | 230,0 mio. |
| Op. cash flow | 543,0 mio. | 480,0 mio. | 210,0 mio. | 300,0 mio. | -131,0 mio. |
| Capex | 335,0 mio. | 360,0 mio. | 467,0 mio. | 415,0 mio. | 469,0 mio. |
| Free cash flow | 208,0 mio. | 120,0 mio. | -257,0 mio. | -115,0 mio. | -600,0 mio. |
| EPS | 3,81 | -3,90 | -1,02 | 0,35 | 1,82 |
| Aktiver i alt | 13.204,0 mio. | 14.054,0 mio. | 14.455,0 mio. | 14.669,0 mio. | 15.217,0 mio. |
| Egenkapital | -1.394,0 mio. | -1.914,0 mio. | -1.392,0 mio. | -1.367,0 mio. | -1.372,0 mio. |
| Rentebærende gæld | 10.396,0 mio. | 11.452,0 mio. | 11.487,0 mio. | 11.635,0 mio. | 12.140,0 mio. |
| Aktier udestående | 138,6 mio. | 138,9 mio. | 136,8 mio. | 134,7 mio. | 132,1 mio. |
Kvartalsregnskab (senest 4 kvartaler)
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | |
|---|---|---|---|---|
| Omsætning | 2.965,0 mio. | — | 9.379,0 mio. | 6.292,0 mio. |
| Bruttoresultat | — | — | — | — |
| Nettoresultat | -58,0 mio. | — | 399,0 mio. | 269,0 mio. |
| Op. cash flow | -297,0 mio. | — | 277,0 mio. | 208,0 mio. |
| Capex | 76,0 mio. | — | 241,0 mio. | 176,0 mio. |
| Free cash flow | -373,0 mio. | — | 36,0 mio. | 32,0 mio. |
| EPS | -0,43 | — | 2,99 | 2,02 |
| Aktiver i alt | 13.180,0 mio. | 13.204,0 mio. | 13.239,0 mio. | 13.641,0 mio. |
| Egenkapital | -1.454,0 mio. | -1.394,0 mio. | -1.502,0 mio. | -1.631,0 mio. |
| Rentebærende gæld | — | — | — | — |
| Aktier udestående | 140,9 mio. | 138,6 mio. | 140,1 mio. | 140,1 mio. |